Nagano, Japan

Hitomi Shimizu

This inventor holds 5 USPTO granted patents, plus 6 CIPO patents and 6 EPO patents. Top assignees: Anaeropharma Science, Inc., Shinshu University. Active years: 2013-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hitomi Shimizu. Retrieved from https://idiyas.com/inventor/hitomi-shimizu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 80.0


 

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Matsumoto, JP (2013)
  • Nagano, JP (2013 - 2020)

Company Filing History:


Years Active: 2013-2020

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Hitomi Shimizu: Innovator in Bacterial Therapeutics

Introduction

Hitomi Shimizu is a prominent inventor based in Nagano, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic bacteria for cancer treatment. With a total of 5 patents, his work focuses on enhancing the efficacy of bacterial therapies in challenging medical conditions.

Latest Patents

One of Shimizu's latest patents is a co-expression plasmid designed to provide an anaerobic enterobacterium with a higher therapeutic effect on anaerobic sites, such as solid tumor tissues and ischemic disease sites. This invention involves a bacterium transformed with a plasmid that co-expresses two types of heterologous polypeptides. The plasmid comprises two secretory expression cassettes, each containing a promoter DNA, a DNA encoding a secretory signal peptide, a DNA encoding a heterologous polypeptide, and a terminator DNA. This innovative approach allows the bacterium to efficiently secrete two types of antibodies that possess anticancer effects.

Another significant patent is related to a heterologous polypeptide expression cassette. The objective of this invention is to provide a signal peptide that can efficiently secrete a heterologous polypeptide outside the bacterial cell. The expression cassette includes a promoter DNA, a DNA encoding the secretory signal peptide, a DNA encoding a scFv antibody with antitumor activity, and a terminator DNA. This invention enables the bacterium to secrete the scFv antibody with high efficiency, enhancing its therapeutic potential.

Career Highlights

Hitomi Shimizu has worked with notable organizations, including Anaeropharma Science, Inc. and Shinshu University. His experience in these institutions has allowed him to advance his research and contribute to the field of bacterial therapeutics.

Collaborations

Shimizu has collaborated with several professionals in his field, including Takeshi Masaki and Yuko Shimatani-Shibata, who is a distinguished female researcher. Their combined efforts have furthered the development of innovative solutions in biotechnology.

Conclusion

Hitomi Shimizu's work in the field of bacterial therapeutics showcases his dedication to advancing medical science. His innovative patents and collaborations highlight his significant contributions to improving treatment options for challenging medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…